Testing and sampling shall where applicable be carried out in accordance with test methods developed by Technical Committee CEN 223 ‘Soil improvers and growing media’ until relevant horizontal standards elaborated under the guidance of CEN Task Force 151 ‘Horizontal’ become available.

- the European Space Agency is responsible for the technical developments of EGNOS and its operation for testing and technical validation purposes.

- the European Space Agency is responsible for the technical developments of EGNOS and its operation for testing and technical validation purposes;

Whereas, therefore, this Directive sets out essential requirements only; whereas, in order to facilitate the task of proving compliance with the essential requirements, harmonized European standards are necessary, more especially with regard to the non-electrical aspects of protection against explosions - standards relating to the design, manufacture and testing of equipment, compliance with which enables a product to be presumed to meet such essential requirements; whereas harmonized European standards are drawn up by private bodies and must retain their non-mandatory status; whereas, for this purpose, the European Committee for Stan ...[+++]dardization (CEN) and the European Committee for Electrotechnical Standardization (Cenelec) are recognized as the bodies competent to adopt harmonized standards which follow the general guidelines for cooperation between the Commission and those two bodies, signed on 13 November 1984; whereas, for the purposes of this Directive, a harmonized standard is a technical specification (European Standard or harmonization document) adopted by one or other of those bodies, or by both, at the prompting of the Commission pursuant to Council Directive 83/189/EEC of the 28 March 1983 providing for a procedure governing the provision of information on technical standards and regulations (1) and pursuant to the general guidelines referred to above;

Whereas changes will be required to the requirements for the testing of veterinary medicinal products laid down in Annex I to Council Directive 81/852/EEC of 28 September 1981 on the approximation of the laws of the Member States relating to analytical , pharmaco-toxicological and clinical standards and protocols in respect of the testing of veterinary medicinal products (7) , as amended by Directive 87/20/EEC (8) , to take account of the special nature of immunological veterinary medicinal products ; whereas the Commission should be ...[+++] empowered to adopt the necessary changes in close cooperation with the Committee for the Adaptation to Technical Progress of the Directives on the Removal of Technical Barriers to Trade in the Veterinary Medicinal Products Sector , thus ensuring greater quality , safety and effectiveness ,

Whereas the Commission should be empowered to adopt, in close cooperation with the Committee for the Adaptation to Technical Progress of the Directives on the Removal of Technical Barriers to Trade in Medicinal Products, any necessary changes in the requirements for the testing of proprietary medicinal products set out in the Annex to Council Directive 75/318/EEC of 20 May 1975 on the approximation of the laws of the Member States relating to analytical, pharmaco-toxicological and clinical standards and protocols in respect of the testing of proprietary medicinal products (1), as last amended by Directive 87/19/EEC (2) ...[+++], to take account of the special nature of medicinal products derived from human blood or human plasma so as to ensure a higher level of quality, safety and efficacy,